Flagship Pioneering, LLC Long-Term Concentrated

CIK: 0001400240 · Show all filings

Period: Q1 2020 (← Previous) (Next →)

Filing Date: May 14, 2020

Total Value ($000): $2,133,438 (100.0% shares, 0.0% debt)

Holdings (8)

MRNA Moderna Inc 71.4%

Value ($000) $1,523,603 Shares 50,871,524 Est. Cost $16.43 Unrealized +40.0%

— Rubius Therapeutics Inc 8.0%

Value ($000) $170,419 Shares 38,296,526 Est. Cost $24.00 Unrealized —

DNLI Denali Therapeutics Inc 6.5%

Value ($000) $139,734 Shares 7,980,263 Est. Cost $17.97 Unrealized +16.1%

KLDO Kaleido Biosciences Inc 5.0%

Value ($000) $106,768 Shares 17,360,710 Est. Cost $13.76 Unrealized -52.6%

— Seres Therapeutics Inc 3.6%

Value ($000) $77,011 Shares 21,571,764 Est. Cost $8.55 Unrealized —

— Evelo Biosciences Inc 3.2%

Value ($000) $68,558 Shares 18,233,403 Est. Cost $11.80 Unrealized —

— Axcella Health Inc 1.4%

Value ($000) $29,920 Shares 8,748,414 Est. Cost $9.31 Unrealized —

— Syros Pharmaceuticals Inc 0.8%

Value ($000) $17,425 Shares 2,938,494 Est. Cost $13.87 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
MRNA	Moderna Inc	50,871,524	$1,523,603	71.4%	$16.43	+40.0%	COM	60770K107
—	Rubius Therapeutics Inc	38,296,526	$170,419	8.0%	$24.00	—	COM	78116T103
DNLI	Denali Therapeutics Inc	7,980,263	$139,734	6.5%	$17.97	+16.1%	COM	24823R105
KLDO	Kaleido Biosciences Inc	17,360,710	$106,768	5.0%	$13.76	-52.6%	COM	483347100
—	Seres Therapeutics Inc	21,571,764	$77,011	3.6%	$8.55	—	COM	81750R102
—	Evelo Biosciences Inc	18,233,403	$68,558	3.2%	$11.80	—	COM	299734103
—	Axcella Health Inc	8,748,414	$29,920	1.4%	$9.31	—	COM	05454B105
—	Syros Pharmaceuticals Inc	2,938,494	$17,425	0.8%	$13.87	—	COM	87184Q107